Analysis of Brentuximab Vedotin Plus CHP (A+CHP) #ASH19 @OfficialUoM

Analysis of Brentuximab Vedotin Plus CHP (A+CHP) #ASH19 ...

Timothy Illidge, MD, PhD of @OfficialUoM provides analysis of brentuximab vedotin plus CHP (A+CHP) in the frontline treatment of patients with CD30+ peripheral T-Cell lymphomas (ECHELON-2).

36 Views
2 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Non-Hodgkin Lymphoma

Alexey Danilov, MD @cityofhope #AACR21 #NonHodgkinLymphoma #Cancer #Research Pharmacologic targeting Mcl-1 with AZD5991 induces apoptosis, suppresses mitochondrial respiration and overcom...
Alexey Danilov, MD @cityofhope #AACR21 #NonHodgkinLymphom...
435 Views
1 year ago
AACR
Want to watch this again later?
Sign in to add this video to a playlist. Login
Danelle James, M.D. @Pharmacyclics #WalenstromsMacroglobulinemia #Non-HodgkinsLymphoma #iNNOVATE #Cancer #Research Ibrutinib U.S. Prescribing Information Updated to Include Long-Term Data...
Danelle James, M.D. @Pharmacyclics #WalenstromsMacroglobu...
88 Views
1 year ago
Cancer
Want to watch this again later?
Sign in to add this video to a playlist. Login
Mazyar Shadman, M.D., M.P.H.@mshadman @fredhutch #Non-HodgkinLymphoma #Cancer #Research Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy
Mazyar Shadman, M.D., M.P.H.@mshadman @fredhutch #Non-Hod...
73 Views
1 year ago
Cancer
Want to watch this again later?
Sign in to add this video to a playlist. Login
Rajat Bannerji, MD, Ph.D. @RutgersCancer #ASH20 #NonHodgkinLymphoma #Cancer #Research 400 Odronextamab (REGN1979)
Rajat Bannerji, MD, Ph.D. @RutgersCancer #ASH20 #NonHodgk...
51 Views
1 year ago
ASH
Want to watch this again later?
Sign in to add this video to a playlist. Login
Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePharma FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePhar...
177 Views
2 years ago
AACR
Want to watch this again later?
Sign in to add this video to a playlist. Login
Caron Jacobson, MD on Interim Analysis of ZUMA-5 #ASCO2020 @DanaFarber
Caron Jacobson, MD on Interim Analysis of ZUMA-5 #ASCO202...
16 Views
2 years ago
Cancer
Want to watch this again later?
Sign in to add this video to a playlist. Login
John Kuruvilla, MD on A New Standard in Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
John Kuruvilla, MD on A New Standard in Phase II Study of...
17 Views
2 years ago
Cancer
Want to watch this again later?
Sign in to add this video to a playlist. Login
John Kuruvilla, MD on the Specific of the Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
John Kuruvilla, MD on the Specific of the Phase II Study ...
47 Views
2 years ago
Cancer
Want to watch this again later?
Sign in to add this video to a playlist. Login
John Kuruvilla, MD on KEYNOTE-204: Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
John Kuruvilla, MD on KEYNOTE-204: Phase II Study of Pemb...
39 Views
2 years ago
Cancer
Want to watch this again later?
Sign in to add this video to a playlist. Login
Eyal Lebel, MD on Recurrence of Cutaneous Anaplastic Large Cell Lymphoma
Eyal Lebel, MD on Recurrence of Cutaneous Anaplastic Larg...
44 Views
2 years ago
Cancer
Want to watch this again later?
Sign in to add this video to a playlist. Login
Zachary Frosch, MD on Needing More Prospective Data in Aggressive B-Cell Lymphoma @PennMedicine #lymphoma
Zachary Frosch, MD on Needing More Prospective Data in Ag...
37 Views
2 years ago
Penn Medicine
Want to watch this again later?
Sign in to add this video to a playlist. Login
Zachary Frosch, MD on Molecular Risk of Stratification: How is it Validated? @PennMedicine #lymphoma
Zachary Frosch, MD on Molecular Risk of Stratification: H...
38 Views
2 years ago
Penn Medicine
Want to watch this again later?
Sign in to add this video to a playlist. Login